EcoDrugPlus

Rho Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSGMOG00000017704
Gene Symbol: ROCK2
3 Cross references
225 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSGMOG00000011444
Gene Symbol: ROCK1
2 Cross references
214 Possible Orthologues:

Sem1 26s Proteasome Complex Subunit

Ensembl ID : ENSGMOG00000026628
Gene Symbol: SEM1
3 Cross references
155 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSGMOG00000030108
Gene Symbol: LOC115556811
2 Cross references
192 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSGMOG00000004818
Gene Symbol: UGCG
2 Cross references
211 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSGMOG00000013026
Gene Symbol: YES1
1 Cross references
208 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSGMOG00000013350
Gene Symbol: ACHE
2 Cross references
233 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSGMOG00000012405
Gene Symbol: ACVR2B
2 Cross references
195 Possible Orthologues:

Activin A Receptor Type 2ba

Ensembl ID : ENSGMOG00000009424
Gene Symbol: ACVR2BA
3 Cross references
193 Possible Orthologues:

Adenosine A2a Receptor A

Ensembl ID : ENSGMOG00000002899
Gene Symbol: ADORA2AA
1 Cross references
189 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSGMOG00000010712
Gene Symbol: ADORA2B
3 Cross references
199 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSGMOG00000011406
Gene Symbol: ADA
1 Cross references
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).